Management of patients with rising prostate-specific antigen after radical prostatectomy

被引：30
|
作者：
Laufer, M
Pound, CR
Carducci, MA
Eisenberger, MA
机构：
[1] Johns Hopkins Univ, Johns Hopkins Oncol Ctr, Sch Med, Baltimore, MD 21287 USA
[2] Tel Aviv Sourasky Med Ctr, Dept Urol, Tel Aviv, Israel
[3] Johns Hopkins Univ, Sch Med, Dept Urol, James Buchanan Brady Urol Inst, Baltimore, MD USA
来源：
UROLOGY | 2000年 / 55卷 / 03期
关键词：
D O I：
10.1016/S0090-4295(99)00465-3
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：309 / 315
页数：7
相关论文
共 50 条
  • [21] The Impact of the Percent of Residual Prostate-Specific Antigen on Metastasis-Free Survival in Patients with Persistent Prostate-Specific Antigen after Radical Prostatectomy
    Lee, Dan Bee
    Kim, Jae Yeon
    Song, Won Hoon
    Nam, Jong Kil
    Lee, Hyun Jung
    Kim, Tae Un
    Park, Sung-Woo
    WORLD JOURNAL OF MENS HEALTH, 2023, 41 (01): : 227 - 235
  • [22] Management of Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy: A Systematic Review of the Literature
    Ploussard, Guillaume
    Fossati, Nicola
    Wiegel, Thomas
    D'Amico, Anthony
    Hofman, Michael S.
    Gillessen, Silke
    Mottet, Nicolas
    Joniau, Steven
    Spratt, Daniel E.
    EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (02): : 150 - 169
  • [23] Performance Characteristics of Prostate-specific Antigen in Patients Undergoing Radical Prostatectomy
    Liu, Jen-Jane
    Ferrari, Michelle
    Nolley, Rosie
    Brooks, James D.
    Presti, Joseph C., Jr.
    UROLOGY, 2012, 79 (06) : 1336 - 1339
  • [24] Is there a prostate-specific antigen upper limit for radical prostatectomy?
    Gontero, Paulo
    Spahn, Martin
    Tombal, Bertrand
    Bader, Pia
    Hsu, Chao-Yu
    Marchioro, Giansilvio
    Frea, Bruno
    Van der Eeckt, Kathy
    Kneitz, Burkhard
    Frohneberg, Detlef
    Tizzani, Alessandro
    Van Poppel, Hendrik
    Joniau, Steven
    BJU INTERNATIONAL, 2011, 108 (07) : 1093 - 1100
  • [25] SALVAGE RADIOTHERAPY FOR RISING PROSTATE-SPECIFIC ANTIGEN LEVELS AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER: DOSE-RESPONSE ANALYSIS
    Bernard, Johnny Ray, Jr.
    Buskirk, Steven J.
    Heckman, Michael G.
    Diehl, Nancy N.
    Ko, Stephen J.
    Macdonald, Orlan K.
    Schild, Steven E.
    Pisansky, Thomas M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03): : 735 - 740
  • [26] Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapy
    Smith, MR
    Manola, J
    Kaufman, DS
    Oh, WK
    Bubley, GJ
    Kantoff, PW
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2723 - 2728
  • [27] A BRIEF REVIEW OF ULTRASENSITIVE PROSTATE-SPECIFIC ANTIGEN ASSAYS FOR THE EVALUATION OF PATIENTS AFTER RADICAL PROSTATECTOMY
    TAKAYAMA, TK
    VESSELLA, RL
    LANGE, PH
    WORLD JOURNAL OF UROLOGY, 1993, 11 (04) : 192 - 195
  • [28] Re: Prostate Cancer-Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era
    Shteynshlyuger, Alex
    Kibel, Adam S.
    EUROPEAN UROLOGY, 2009, 56 (06) : 1089 - 1090
  • [29] Validation of schedules for optimal prostate-specific antigen monitoring after radical prostatectomy
    Blas, Leandro
    Shiota, Masaki
    Tanegashima, Tokiyoshi
    Tsukahara, Shigehiro
    Ueda, Shohei
    Mutaguchi, Jun
    Goto, Shunsuke
    Kobayashi, Satoshi
    Matsumoto, Takashi
    Inokuchi, Junichi
    Eto, Masatoshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (04) : 404 - 408
  • [30] Elimination kinetics of prostate-specific antigen as predictor of prognosis after radical prostatectomy
    Hamm, M
    Semjonow, A
    Oberpenning, F
    Mandt, S
    Rathert, P
    AKTUELLE UROLOGIE, 1996, 27 (06) : 385 - 389
12345